Impact of Left Ventricular Assist Devices on Quality of Life in End-Stage Heart Failure Patients: A Comprehensive Assessment
DOI:
https://doi.org/10.52783/jns.v14.3254Keywords:
Left Ventricular Assist Device (LVAD), Quality of Life (QOL), End-Stage Heart Failure, Functional Capacity and Cardiac FunctionAbstract
Introduction: Left Ventricular Assist Devices (LVADs) are crucial treatments for end-stage heart failure patients, either as a bridge to heart transplantation or as a long-term solution. This study evaluates the impact of LVAD therapy on quality of life (QOL), focusing on both physical and psychological outcomes.
Methods: The study assessed QOL using multiple measures: the EQ-5D for general health, PHQ-9 for depressive symptoms, Heart Muscle Recovery Score (HMRS) for cardiac function, and the 6-Minute Walk Test (6MWT) for functional capacity. Data was collected from multiple clinical studies, and the results were analyzed to determine improvements in physical and mental health post-LVAD implantation.
Results: LVAD implantation led to significant improvements in physical health, as demonstrated by increased endurance and functional capacity in the 6MWT. Cardiac function recovery was also noted, with a marked improvement in heart muscle recovery. In terms of psychological health, depressive symptoms remained a concern, with varying levels of depression observed in different studies. While some patients showed mild symptoms of depression, others reported more significant psychological distress. The EQ-5D scores indicated moderate to significant improvements in overall health-related QOL.
Conclusion: LVAD therapy significantly improves physical health and functional capacity in end-stage heart failure patients. However, mental health issues, particularly depression, persist in some patients, highlighting the need for ongoing psychological support. Integrating mental health care into LVAD management is essential for optimizing patient outcomes. Further research is needed to better understand the long-term psychological effects of LVAD therapy. significant therapeutic interventions. Moreover, DDS is the latest advanced technological to overcome the limitations of the existing drug administration’s such as bioavailability, low solubility, abbreviated half-life, etc. Here, this study discusses the recent technologies which based on healthcare innovation related models are explored
Downloads
Metrics
References
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023 Jan 18;118(17):3272-3287. doi: 10.1093/cvr/cvac013. Erratum in: Cardiovasc Res. 2023 Jun 13;119(6):1453. doi: 10.1093/cvr/cvad026. PMID: 35150240.
Bozkurt B, Ahmad T, Alexander KM, Baker WL, Bosak K, Breathett K, Fonarow GC, Heidenreich P, Ho JE, Hsich E, Ibrahim NE, Jones LM, Khan SS, Khazanie P, Koelling T, Krumholz HM, Khush KK, Lee C, Morris AA, Page RL 2nd, Pandey A, Piano MR, Stehlik J, Stevenson LW, Teerlink JR, Vaduganathan M, Ziaeian B; Writing Committee Members. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America. J Card Fail. 2023 Oct;29(10):1412-1451. doi: 10.1016/j.cardfail.2023.07.006. Epub 2023 Sep 26. PMID: 37797885; PMCID: PMC10864030.
Holley CT, Harvey L, John R. Left ventricular assist devices as a bridge to cardiac transplantation. J Thorac Dis. 2014 Aug;6(8):1110-9. doi: 10.3978/j.issn.2072-1439.2014.06.46. PMID: 25132978; PMCID: PMC4133552.
Tu J, Xu L, Li F, Dong N. Developments and Challenges in Durable Ventricular Assist Device Technology: A Comprehensive Review with a Focus on Advancements in China. J Cardiovasc Dev Dis. 2024 Jan 18;11(1):29. doi: 10.3390/jcdd11010029. PMID: 38248899; PMCID: PMC10817065.
Chaudhry SP, DeVore AD, Vidula H, Nassif M, Mudy K, Birati EY, Gong T, Atluri P, Pham D, Sun B, Bansal A, Najjar SS; Future Leaders In Growing Heart Failure Therapies (FLIGHT) Investigators. Left Ventricular Assist Devices: A Primer For the General Cardiologist. J Am Heart Assoc. 2022 Dec 20;11(24):e027251. doi: 10.1161/JAHA.122.027251. Epub 2022 Dec 14. PMID: 36515226; PMCID: PMC9798797.
Afzal S, Abdul Manap AS, Attiq A, Albokhadaim I, Kandeel M, Alhojaily SM. From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration. Front Pharmacol. 2023 Oct 18;14:1269581. doi: 10.3389/fphar.2023.1269581. PMID: 37927596; PMCID: PMC10622810.
Garbade J, Bittner HB, Barten MJ, Mohr FW. Current trends in implantable left ventricular assist devices. Cardiol Res Pract. 2011;2011:290561. doi: 10.4061/2011/290561. Epub 2011 May 9. PMID: 21822483; PMCID: PMC3099197.
Eisen HJ. Left Ventricular Assist Devices (LVADS): History, Clinical Application and Complications. Korean Circ J. 2019 Jul;49(7):568-585. doi: 10.4070/kcj.2019.0161. PMID: 31243930; PMCID: PMC6597447.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097. Epub 2009 Jul 21. PMID: 19621072; PMCID: PMC2707599.
Boston RC, Sumner AE. STATA: a statistical analysis system for examining biomedical data. Adv Exp Med Biol. 2003;537:353-69. doi: 10.1007/978-1-4419-9019-8_23. PMID: 14995047.
Ammirati E, Oliva FG, Colombo T, Russo CF, Cipriani MG, Garascia A, Guida V, Colombo G, Verde A, Perna E, Cannata A, Paino R, Martinelli L, Frigerio M. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation. Heart Vessels. 2016 May;31(5):722-33. doi: 10.1007/s00380-015-0654-4. Epub 2015 Mar 4. PMID: 25735775.
Ammirati E, Cipriani MG, Varrenti M, Colombo T, Garascia A, Cannata A, Pedrazzini G, Benazzi E, Milazzo F, Oliva F, Gagliardone MP, Russo CF, Frigerio M. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2016 Oct;23(4):584-92. doi: 10.1093/icvts/ivw164. Epub 2016 May 30. PMID: 27245619.
Carrozzini M, Bejko J, Gambino A, Tarzia V, Lanera C, Gregori D, Gerosa G, Bottio T. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant. J Cardiovasc Med (Hagerstown). 2018 Dec;19(12):739-747. doi: 10.2459/JCM.0000000000000721. PMID: 30300244.
Starling RC, Estep JD, Horstmanshof DA, Milano CA, Stehlik J, Shah KB, Bruckner BA, Lee S, Long JW, Selzman CH, Kasirajan V, Haas DC, Boyle AJ, Chuang J, Farrar DJ, Rogers JG; ROADMAP Study Investigators. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results. JACC Heart Fail. 2017 Jul;5(7):518-527. doi: 10.1016/j.jchf.2017.02.016. Epub 2017 Apr 5. PMID: 28396040.
Hasin T, Marmor Y, Kremers W, Topilsky Y, Severson CJ, Schirger JA, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Park SJ, Kushwaha SS. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol. 2013 Jan 15;61(2):153-63. doi: 10.1016/j.jacc.2012.09.041. Epub 2012 Dec 5. PMID: 23219299.
Morgan JA, Paone G, Nemeh HW, Murthy R, Williams CT, Lanfear DE, Tita C, Brewer RJ. Impact of continuous-flow left ventricular assist device support on right ventricular function. J Heart Lung Transplant. 2013 Apr;32(4):398-403. doi: 10.1016/j.healun.2012.12.018. Epub 2013 Feb 9. PMID: 23402946.
Stehlik J, Estep JD, Selzman CH, Rogers JG, Spertus JA, Shah KB, Chuang J, Farrar DJ, Starling RC; ROADMAP Study Investigators. Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management). Circ Heart Fail. 2017 Jun;10(6):e003910. doi: 10.1161/CIRCHEARTFAILURE.116.003910. PMID: 28611126.
Takeda K, Takayama H, Kalesan B, Uriel N, Colombo PC, Jorde UP, Naka Y. Long-term outcome of patients on continuous-flow left ventricular assist device support. J Thorac Cardiovasc Surg. 2014 Oct;148(4):1606-14. doi: 10.1016/j.jtcvs.2014.04.009. Epub 2014 Apr 12. PMID: 25260275.
Bekono-Nessah I, Rosenburg A, Bowles CT, Riesgo-Gil F, Stock U, Szydlo RR, Laffan M, Arachchillage DJ. Bleeding and thrombotic complications and their impact on mortality in patients supported with left ventricular assist device for cardiogenic shock. Perfusion. 2023 Nov;38(8):1670-1681. doi: 10.1177/02676591221127651. Epub 2022 Sep 23. PMID: 36148887; PMCID: PMC11057213.
Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001 Nov 15;345(20):1435-43. doi: 10.1056/NEJMoa012175. PMID: 11794191.
Starling, R. C., J. D. Estep, D. A. Horstmanshof, C. A. Milano, J. Stehlik, K. B. Shah, B. A. Bruckner, S. Lee, J. W. Long, C. H. Selzman, V. Kasirajan, D. C. Haas, A. J. Boyle, J. Chuang, D. J. Farrar, and J. G. Rogers. 2017. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients. JACC Heart Failure. Volume 5(7), pages 518–527.
Balestroni G, Bertolotti G. L'EuroQol-5D (EQ-5D): uno strumento per la misura della qualità della vita [EuroQol-5D (EQ-5D): an instrument for measuring quality of life]. Monaldi Arch Chest Dis. 2012 Sep;78(3):155-9. Italian. doi: 10.4081/monaldi.2012.121. PMID: 23614330.
Alnsasra H, Khalil F, Kanneganti Perue R, Azab AN. Depression among Patients with an Implanted Left Ventricular Assist Device: Uncovering Pathophysiological Mechanisms and Implications for Patient Care. Int J Mol Sci. 2023 Jul 10;24(14):11270. doi: 10.3390/ijms241411270. PMID: 37511030; PMCID: PMC10379142.
Lakhani HA, Lizarzaburo Penafiel LS, Fakhoury M, Seide M, Duran S PX, See JW, Dhillon DK, Shah S, Khan AM, Nimmagadda M, Susmitha T, Rai M. Heart Transplantation and Left Ventricular Assist Devices: Long-Term Prognosis and Effects on Mental Health. Cureus. 2024 Sep 5;16(9):e68691. doi: 10.7759/cureus.68691. PMID: 39371854; PMCID: PMC11452842
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
